A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction

Contemporary Clinical Trials(2009)

引用 24|浏览7
暂无评分
摘要
Major Depression with Psychotic Features (psychotic depression) is a common, debilitating psychiatric disease. We hypothesized that mifepristone, a cortisol receptor (GRII) antagonist, would significantly reduce psychotic symptoms in psychotic depression.
更多
查看译文
关键词
Psychotic depression,Mifepristone,Site effects,Site-by-treatment interaction
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要